Outlook Therapeutics Inc
NASDAQ:OTLK
Income Statement
Earnings Waterfall
Outlook Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-47.8m
USD
|
Operating Income
|
-47.8m
USD
|
Other Expenses
|
-3.7m
USD
|
Net Income
|
-51.5m
USD
|
Income Statement
Outlook Therapeutics Inc
Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||
Revenue |
5
N/A
|
3
-38%
|
4
+15%
|
3
-21%
|
3
+1%
|
2
-24%
|
2
-30%
|
1
-12%
|
4
+174%
|
4
+12%
|
5
+11%
|
5
+10%
|
3
-41%
|
3
+9%
|
3
-4%
|
3
-6%
|
8
+166%
|
7
-13%
|
6
-9%
|
6
-9%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||||||||||||||||||||||||||
Operating Expenses |
(52)
|
(62)
|
(52)
|
(62)
|
(54)
|
(55)
|
(59)
|
(44)
|
(40)
|
(25)
|
(25)
|
(25)
|
(33)
|
(38)
|
(38)
|
(36)
|
(33)
|
(32)
|
(31)
|
(37)
|
(36)
|
(37)
|
(49)
|
(48)
|
(52)
|
(51)
|
(57)
|
(64)
|
(63)
|
(66)
|
(54)
|
(55)
|
(53)
|
(48)
|
|
Selling, General & Administrative |
(13)
|
(16)
|
(12)
|
(20)
|
(22)
|
(22)
|
(26)
|
(19)
|
(16)
|
(15)
|
(13)
|
(12)
|
(14)
|
(14)
|
(13)
|
(13)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(12)
|
(12)
|
(13)
|
(14)
|
(16)
|
(19)
|
(21)
|
(23)
|
(23)
|
(24)
|
(27)
|
(27)
|
|
Research & Development |
(39)
|
(46)
|
(40)
|
(42)
|
(33)
|
(33)
|
(33)
|
(25)
|
(24)
|
(11)
|
(12)
|
(13)
|
(19)
|
(24)
|
(25)
|
(24)
|
(24)
|
(24)
|
(22)
|
(26)
|
(26)
|
(32)
|
(37)
|
(37)
|
(39)
|
(37)
|
(41)
|
(43)
|
(42)
|
(42)
|
(31)
|
(30)
|
(26)
|
(21)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(47)
N/A
|
(59)
-26%
|
(48)
+19%
|
(59)
-23%
|
(51)
+13%
|
(53)
-3%
|
(58)
-9%
|
(43)
+25%
|
(36)
+16%
|
(21)
+42%
|
(20)
+5%
|
(20)
+1%
|
(30)
-50%
|
(34)
-16%
|
(35)
-1%
|
(33)
+5%
|
(25)
+24%
|
(25)
-1%
|
(25)
+3%
|
(31)
-25%
|
(36)
-18%
|
(37)
-1%
|
(49)
-33%
|
(48)
+1%
|
(52)
-7%
|
(51)
+2%
|
(57)
-12%
|
(64)
-12%
|
(63)
+1%
|
(66)
-4%
|
(54)
+18%
|
(55)
-2%
|
(53)
+3%
|
(48)
+10%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||
Interest Income Expense |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(6)
|
(6)
|
(6)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(3)
|
(2)
|
(2)
|
1
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(12)
|
(18)
|
(17)
|
(11)
|
(2)
|
0
|
6
|
0
|
0
|
(1)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
4
|
3
|
4
|
3
|
(1)
|
1
|
3
|
1
|
3
|
2
|
1
|
4
|
2
|
2
|
2
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(3)
|
(4)
|
(5)
|
|
Pre-Tax Income |
(49)
N/A
|
(61)
-25%
|
(50)
+18%
|
(61)
-21%
|
(53)
+12%
|
(55)
-4%
|
(60)
-8%
|
(43)
+28%
|
(38)
+11%
|
(24)
+37%
|
(24)
+2%
|
(27)
-13%
|
(34)
-25%
|
(38)
-14%
|
(41)
-7%
|
(38)
+8%
|
(38)
0%
|
(45)
-18%
|
(40)
+10%
|
(41)
-3%
|
(39)
+7%
|
(36)
+6%
|
(44)
-20%
|
(50)
-14%
|
(53)
-7%
|
(53)
N/A
|
(60)
-12%
|
(65)
-9%
|
(66)
-1%
|
(70)
-6%
|
(57)
+19%
|
(60)
-5%
|
(59)
+2%
|
(51)
+13%
|
|
Net Income | |||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
3
|
3
|
3
|
4
|
1
|
1
|
1
|
3
|
0
|
0
|
6
|
3
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
Income from Continuing Operations |
(49)
|
(61)
|
(50)
|
(61)
|
(53)
|
(56)
|
(60)
|
(43)
|
(39)
|
(22)
|
(21)
|
(24)
|
(30)
|
(38)
|
(41)
|
(37)
|
(35)
|
(41)
|
(37)
|
(35)
|
(35)
|
(33)
|
(41)
|
(50)
|
(53)
|
(53)
|
(60)
|
(65)
|
(66)
|
(70)
|
(57)
|
(60)
|
(59)
|
(51)
|
|
Income to Minority Interest |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(53)
N/A
|
(64)
-20%
|
(53)
+17%
|
(71)
-33%
|
(63)
+11%
|
(64)
-2%
|
(68)
-5%
|
(43)
+37%
|
(40)
+7%
|
(39)
+3%
|
(39)
-1%
|
(43)
-10%
|
(48)
-12%
|
(40)
+16%
|
(43)
-7%
|
(38)
+10%
|
(36)
+6%
|
(45)
-24%
|
(51)
-14%
|
(49)
+3%
|
(49)
+1%
|
(45)
+8%
|
(41)
+10%
|
(50)
-23%
|
(53)
-7%
|
(53)
0%
|
(60)
-12%
|
(65)
-9%
|
(66)
-1%
|
(70)
-6%
|
(57)
+19%
|
(60)
-5%
|
(59)
+2%
|
(51)
+13%
|
|
EPS (Diluted) |
-18.59
N/A
|
-22.31
-20%
|
-29.98
-34%
|
-30.14
-1%
|
-29.36
+3%
|
-22.21
+24%
|
-22.86
-3%
|
-14.06
+38%
|
-13.33
+5%
|
-12.35
+7%
|
-12.16
+2%
|
-9.93
+18%
|
-9.74
+2%
|
-4.08
+58%
|
-3.72
+9%
|
-1.67
+55%
|
-1.98
-19%
|
-1.49
+25%
|
-1.06
+29%
|
-0.54
+49%
|
-0.67
-24%
|
-0.36
+46%
|
-0.26
+28%
|
-0.29
-12%
|
-0.35
-21%
|
-0.28
+20%
|
-0.27
+4%
|
-0.29
-7%
|
-0.31
-7%
|
-0.31
N/A
|
-0.22
+29%
|
-0.25
-14%
|
-0.24
+4%
|
-3.95
-1 546%
|